BenzePrO

Manufacturer
PruGen, Inc. | Span Packing Services
Effective date
2022-01-19
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:39:25

Label at a glance#

ProductBenzePrO
Active ingredientBenzoyl Peroxide
Label structure13 sections

Indications and uses

BenzePrO ® Foaming Cloths are indicated for use in the topical treatment of mild to moderate acne vulgaris.

Dosage and administration

Avoid contact with hair, fabrics or carpeting as benzoyl peroxide will cause bleaching or discoloration. Wash affected areas once or twice daily, or as directed by your physician. Wet face with water. Wet cloth with a little waterand work into a full lather. Cleanse face with cloth for 10-20 seconds avoiding eyes. Rinse thoroughly and pat dry. Throw away cloth. Do not flush. If going outside, apply sunscreen after...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

DESCRIPTION

DESCRIPTION SECTION

BenzePrO® Foaming Cloths are a topical preparation containing 6.0% benzoyl peroxide. Each gram of BenzePrO® Foaming Cloths wash contains 60 mg of Benzoyl Peroxide as micronized particles. Ingredients include Purified Water, Carbomer 1342, Sodium Hyaluronate, Cetyl Alcohol, Glycerine, Hydroxypropyl Methylcellulose, Sodium Cocoyl Isethionate, Sodium Methyl Cocoyl Taurate, Sodium Lauryl Sulfoacetate and Disodium Laureth Sulfosuccinate, Sodium PCA, Sodium Hydroxide 10% Solution, Zinc Lactate, Citric Acid, Sodium Citrate, Benzoyl Peroxide 6.0%, Docusate Sodium.

Benzoyl peroxide is an oxidizing agent that possesses antibacterial properties and is classified as a keratolytic. Benzoyl peroxide (C14H10O4) is represented by the following structure:

Chemical Structure
Chemical Structure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

The exact method of action of benzoyl peroxide in acne vulgaris is not known. Benzoyl peroxide is an antibacterial agent with demonstrated activity against Propionibacterium acnes. This action, combined with the mild keratolytic effect of benzoyl peroxide, is believed to be responsible for its usefulness in acne. Benzoyl peroxide is absorbed by the skin where it is metabolized to benzoic acid and excreted as benzoate in the urine.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

BenzePrO® Foaming Cloths are indicated for use in the topical treatment of mild to moderate acne vulgaris.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

BenzePrO® Foaming Cloths should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product. Discontinue use if hypersensitivity is observed.

WARNINGS

WARNINGS SECTION

FOR EXTERNAL USE ONLY. Not For Ophthalmic Use. Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

When using this product, skin irritation and dryness is more likely to occur if:

  • you leave BenzePrO® Foaming Cloths on your skin longer than directed
  • you use another topical acne medication at the same time

Do not use this product if you:

  • have very sensitive skin
  • are sensitive to benzoyl peroxide

When using this product:

  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with the eyes, lips, mouth
  • avoid contact with hair and dyed fabrics, which may be bleached by this product
  • skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in lower concentration.

Stop use and ask a doctor:

  • if irritation becomes severe.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

If severe irritation develops, discontinue use and institute appropriate therapy.

Information for patients

INFORMATION FOR PATIENTS SECTION

This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. Avoid contact with eyes, eyelids, lips, and mucous membranes. If accidental contact occurs, rinse with water. If excessive redness or irritation develops, discontinue use and consult your physician.

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Based upon all available evidence, benzoyl peroxide is not considered to be a carcinogen. However, data from a study using mice known to be highly susceptible to cancer suggest that benzoyl peroxide acts as a tumor promoter. The clinical significance of the findings is not known.

Pregnancy

PREGNANCY SECTION

Category C animal reproduction studies have not been conducted with benzoyl peroxide. It is also not known whether benzoyl peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl peroxide should be used by a pregnant woman only if clearly needed.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in the human milk. Because many drugs are excreted in human milk, caution should be exercised when benzoyl peroxide is administered to a nursing woman.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in children below the age of 12 have not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy.

OVERDOSAGE

OVERDOSAGE SECTION

If excessive scaling, erythema or edema occurs, the use of this preparation should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Avoid contact with hair, fabrics or carpeting as benzoyl peroxide will cause bleaching or discoloration.

Wash affected areas once or twice daily, or as directed by your physician.

  1. Wet face with water.
  2. Wet cloth with a little waterand work into a full lather.
  3. Cleanse face with cloth for 10-20 seconds avoiding eyes.
  4. Rinse thoroughly and pat dry.
  5. Throw away cloth. Do not flush.
  • If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.

HOW SUPPLIED

HOW SUPPLIED SECTION

BenzePrO® Foaming Cloths are supplied in a carton containing 60 × 3.2 g individually wrapped benzoyl peroxide 6% foaming cloths (NDC 42546-016-60).

STORAGE AND HANDLING SECTION

Store at room temperature: 15° - 25°C (59° - 77°F). Protect from freezing.

SPL UNCLASSIFIED SECTION

Manufactured for:
PruGen Pharmaceuticals
18899 N Thompson Peak Pkwy
Scottsdale, AZ 85255
www.prugen.com

Rev. 3.0

PRINCIPAL DISPLAY PANEL - 60 Cloth Packet Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 42546-016-60
Rx only

BenzePrO®

Foaming Cloths
benzoyl peroxide 6.0%

60
cloths
Net wt. 3.2 g each

PRUGEN
PHARMACEUTICALS

PRINCIPAL DISPLAY PANEL - 60 Cloth Packet Carton
PRINCIPAL DISPLAY PANEL - 60 Cloth Packet Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1605441Benzepro 6 % Medicated TowelettePSN2
797704benzoyl peroxide 6 % Medicated PadPSN2
1605441benzoyl peroxide 60 MG/ML Medicated Pad [Benzepro]SBD2
797704benzoyl peroxide 60 MG/ML Medicated PadSCD2
1605441Benzepro 6 % Medicated ToweletteSY2
797704benzoyl peroxide 6 % Medicated PadSY2
797704benzoyl peroxide 6 % ToweletteSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d9d61457-6a5a-41fc-b418-e5479a2904b7Product name220230303
32012d5c-25ac-49c7-9d4c-1313177fff7cProduct name120230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
3f45980c-c196-47e5-0e5e-48b7c57327c5Product name520200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfaProduct name120170810

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
42546-016-602024-01-30C16284748780-11030e365-24bc-111a-e063-dadaa90a10e2BenzePrO ® Foaming Cloths benzoyl peroxide 6.0%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42546-016-60BenzePrO1 in 1 PACKETCLOTH12
42546-016-60BenzePrO60 in 1 CARTONCLOTH602

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42546-016BENZEPRO (BENZOYL PEROXIDE) CLOTH [PRUGEN, INC.]2Legacy NDC, 2 package rows20220121_8e13d1bb-a124-4ffd-8aed-aaab080b7535.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42546-016-60EA - Each42546-016638d7b04-a15d-4596-98ff-354be3e98b5c12017-12-14

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
42546-01642546-016-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
46325f30-874f-4a29-8c44-091293ff518a8e13d1bb-a124-4ffd-8aed-aaab080b75352022-01-19Warnings, Adverse reactionsExact identifier
spl id: 46325f30-874f-4a29-8c44-091293ff518a
spl set id: 8e13d1bb-a124-4ffd-8aed-aaab080b7535

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.